CapsoVision (CV) Reiterated at Speculative Buy by Benchmark After Q1 Results May 15, 2026 07:55AM
CapsoVision (CV) Misses Q1 EPS by 4c May 14, 2026 04:21PM
CapsoVision Inc (CV) PT Lowered to $10 at Benchmark, Estimates Adjusted Mar 27, 2026 08:21AM
CapsoVision Inc (CV) PT Raised to $11 at Roth/MKM Mar 23, 2026 12:08PM
CapsoVision submits FDA application for AI-assisted capsule endoscopy module Dec 29, 2025 04:05PM


Nov 14, 2025 09:58AM Benchmark Reiterates Speculative Buy Rating on CapsoVision Inc (CV)
Nov 13, 2025 05:56PM CapsoVision (CV) Reports Q3 Loss of $0.17
Nov 10, 2025 04:06PM CapsoVision seeks FDA breakthrough status for pancreatic cancer capsule
Aug 15, 2025 07:11AM CapsoVision (CV) Misses Q2 EPS by 202c
Jul 28, 2025 07:23AM Benchmark Starts CapsoVision Inc (CV) at Speculative Buy
Jul 28, 2025 02:18AM Roth/MKM Starts CapsoVision Inc (CV) at Buy
Jul 3, 2025 07:17AM Recent IPO CapsoVision (CV) Surges 140%
Jul 2, 2025 10:55AM Capsovision (CV) Opens At $5, IPO Priced At $5
Jul 2, 2025 06:00AM CapsoVision (CV) Prices 5.5M Share IPO at $5/sh
Jun 27, 2025 06:06AM CapsoVision (CV) Files for 5.25M Share IPO at $5-$5.50/sh
May 9, 2025 04:15PM CapsoVision (CV) Files for Proposed IPO